Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
OPKO Health runs medical testing labs and sells prescription drugs and diagnostic products to patients, doctors, and healthcare providers.
OPKO Health is a healthcare company with two main jobs: running clinical laboratories that process blood and other medical tests for doctors and patients, and selling pharmaceuticals, including its own specialty drugs and diagnostic products. It sits in the messy middle of medicine — the part that actually gets a test result back to a doctor or a prescription into a patient's hands.
The lab side, run through its BioReference business, is the biggest piece. Hospitals and physician offices send specimens in, and OPKO's labs run the tests and bill insurers or patients for the work. This is a volume business with thin margins: the equipment and staff cost a lot whether or not the machines are busy, so the key is keeping test volumes high and getting paid reliably. The drug side includes a portfolio of medicines sold to pharmacies and providers, plus diagnostic tests and products sold to other labs and health systems. The company has been a long-time vehicle for its chairman and largest shareholder, Phillip Frost, a serial healthcare entrepreneur. OPKO has grown largely by buying things — labs, drug developers, diagnostic assets — rather than through slow internal expansion, and it has a history of losses and debt. Its stock is volatile and heavily tied to news about its pipeline, lab volumes, and payer contracts.
The simple version: OPKO is a collection of healthcare businesses that make money by running tests and selling medicines. Its big challenge is that lab testing is a brutal, competitive, low-margin game dominated by larger players, so the company's future depends on keeping volumes up, controlling costs, and turning promising drugs and tests into real revenue.
Saved answer · last researched 15 Nov 2026